{"id":20467,"date":"2026-10-09T07:51:52","date_gmt":"2026-10-09T07:51:52","guid":{"rendered":"https:\/\/veilles-affaires-sociales.fr\/?p=20467"},"modified":"2026-10-09T07:51:52","modified_gmt":"2026-10-09T07:51:52","slug":"duloxetine-lansm-demande-aux-laboratoires-de-renforcer-leurs-approvisionnements","status":"publish","type":"post","link":"https:\/\/veilles-affaires-sociales.fr\/?p=20467","title":{"rendered":"Dulox\u00e9tine : l\u2019ANSM demande aux laboratoires de renforcer leurs approvisionnements"},"content":{"rendered":"<p>L\u2019Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM) signale, au 9 octobre 2026, des difficult\u00e9s d\u2019approvisionnement en m\u00e9dicaments \u00e0 base de dulox\u00e9tine, dos\u00e9s \u00e0 30 mg et 60 mg en g\u00e9lules gastro-r\u00e9sistantes, en raison de probl\u00e8mes temporaires de production. Les laboratoires concern\u00e9s annoncent un retour progressif \u00e0 une situation normale dans les pharmacies \u00e0 partir de la mi-novembre.<\/p>\n<p>La dulox\u00e9tine est indiqu\u00e9e dans le traitement des \u00e9pisodes d\u00e9pressifs majeurs, du trouble anxieux g\u00e9n\u00e9ralis\u00e9 et de certaines douleurs neuropathiques, notamment chez les personnes atteintes de diab\u00e8te. Afin de pr\u00e9server l\u2019acc\u00e8s au traitement pour les patients d\u00e9j\u00e0 sous dulox\u00e9tine pendant cette p\u00e9riode transitoire, l\u2019ANSM demande aux laboratoires de mettre le maximum de bo\u00eetes en circulation, y compris en mobilisant leurs stocks de s\u00e9curit\u00e9, et de limiter les initiations de traitement.<\/p>\n<p>Pour favoriser une r\u00e9partition g\u00e9ographique \u00e9quitable des stocks disponibles, l\u2019ANSM demande aux laboratoires de privil\u00e9gier l\u2019approvisionnement des pharmacies d\u2019officine via les grossistes-r\u00e9partiteurs et de limiter les ventes directes. Ces mesures visent \u00e0 s\u00e9curiser la continuit\u00e9 th\u00e9rapeutique dans un contexte de tension d\u2019approvisionnement sur un m\u00e9dicament utilis\u00e9 en psychiatrie et en prise en charge de la douleur.\u00a0(contenu r\u00e9sum\u00e9 par l&rsquo;IA)<a href=\"https:\/\/ansm.sante.fr\/actualites\/duloxetine-lansm-demande-aux-laboratoires-de-renforcer-leurs-approvisionnements\" target=\"_blank\" class=\"feedzy-rss-link-icon\">Lire la Suite<\/a>\u200b<\/p>","protected":false},"excerpt":{"rendered":"<p>L\u2019Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM) signale, au 9 octobre 2026, des difficult\u00e9s d\u2019approvisionnement en m\u00e9dicaments \u00e0 base de dulox\u00e9tine, dos\u00e9s \u00e0 30 mg [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3852,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[7],"tags":[63,227],"class_list":["post-20467","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicaments-et-produits-de-sante","tag-ansm","tag-ia"],"_links":{"self":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts\/20467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=20467"}],"version-history":[{"count":0,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts\/20467\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/media\/3852"}],"wp:attachment":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=20467"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=20467"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=20467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}